Concourse Financial Group Securities, Inc. M Dx Health Sa Transaction History

Concourse Financial Group Securities, Inc.

$1.52 Billion
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$2.69 - $3.86 $0 - $0	0 New	0 $0
Q3 2023 Oct 25, 2023	BUY	$2.69 - $3.86 $0 - $0	0 New	0 $0
Q2 2023 Aug 10, 2023	BUY	$3.07 - $4.2 $0 - $0	0 New	0 $0
Q1 2023 May 15, 2023	BUY	$2.61 - $7.15 $0 - $0	0 New	0 $0
Q4 2022 Jan 30, 2023	BUY	$6.2 - $8.36 $0 - $0	0 New	0 $0

Q3 2022 Nov 15, 2022	BUY	$6.65 - $8.84 $0 - $0	0 New	0 $0
Q2 2022 Aug 09, 2022	BUY	$6.65 - $9.33 $0 - $0	0 New	0 $0
Q1 2022 May 09, 2022	BUY	$7.69 - $10.27 $0 - $0	0 New	0 $0
Q4 2021 Feb 07, 2022	BUY	$8.45 - $12.0 $0 - $0	0 New	0 $0

Others Institutions Holding MDXH

# of Institutions

Shares Held

9.5K

Call Options Held

Put Options Held

Bergan Kdv Wealth Management, LLC

9.5K
Shares

$22,135
0.0% of portfolio

View Full List

About MDxHealth SA

Ticker MDXH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,288,100
Market Cap $38M
Description
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...

More about MDXH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account